These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25274668)

  • 1. New grants to boost genome sequencing.
    Cancer Discov; 2014 Oct; 4(10):1110-1. PubMed ID: 25274668
    [No Abstract]   [Full Text] [Related]  

  • 2. NHGRI seeks to fund new genomic-based research studies in Africa.
    Boughton B
    Clin Transl Sci; 2011 Aug; 4(4):230. PubMed ID: 21991628
    [No Abstract]   [Full Text] [Related]  

  • 3. Leading the way to genomic medicine.
    Manolio TA; Green ED
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):1-7. PubMed ID: 24619573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of whole-genome sequencing in healthy individuals: what can we learn from CEAs of whole-body CT screening?
    Lu CY
    Genet Med; 2016 Jan; 18(1):103-4. PubMed ID: 26633543
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise of nanopore technology: Nanopore DNA sequencing represents a fundamental change in the way that genomic information is read, with potentially big savings.
    Rosenstein J
    IEEE Pulse; 2014; 5(4):52-4. PubMed ID: 25029683
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to Phillips et al.
    Bennette CS; Burke W; Jarvik GP; Veenstra DL
    Genet Med; 2015 Apr; 17(4):315. PubMed ID: 25835196
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving genome assemblies by sequencing PCR products with PacBio.
    Zhang X; Davenport KW; Gu W; Daligault HE; Munk AC; Tashima H; Reitenga K; Green LD; Han CS
    Biotechniques; 2012 Jul; 53(1):61-2. PubMed ID: 22780321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 24-hour, $1,000 genome.
    Scudellari M
    Cancer Discov; 2012 Apr; 2(4):OF6. PubMed ID: 22576221
    [No Abstract]   [Full Text] [Related]  

  • 9. Illumina claims $1,000 genome win.
    Sheridan C
    Nat Biotechnol; 2014 Feb; 32(2):115. PubMed ID: 24509738
    [No Abstract]   [Full Text] [Related]  

  • 10. Key emerging themes for assessing the cost-effectiveness of reporting incidental findings.
    Phillips KA; Ladabaum U; Pletcher MJ; Marshall DA; Douglas MP
    Genet Med; 2015 Apr; 17(4):314-5. PubMed ID: 25835195
    [No Abstract]   [Full Text] [Related]  

  • 11. [Novel high-throughput sequencing strategies in genetic diagnostics].
    Myllykangas S; Koskenvuo JW; Alastalo TP
    Duodecim; 2013; 129(2):141-8. PubMed ID: 23577577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can a new microscopy platform help to improve clinical outcomes?
    Koebley SR; Reed J
    Biotechniques; 2018 Nov; 65(5):250-251. PubMed ID: 30394133
    [No Abstract]   [Full Text] [Related]  

  • 13. [Genomic medicine: the new way of thinking medicine present and future--Part two].
    Lamoril J; Bogard M
    Ann Biol Clin (Paris); 2014; 72(1):25-48. PubMed ID: 24492096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massively parallel sequencing technology in pathogenic microbes.
    Tripathy S; Jiang RH
    Methods Mol Biol; 2012; 835():271-94. PubMed ID: 22183660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis.
    Mardis E; Raison C
    Expert Rev Mol Diagn; 2015 Apr; 15(4):449-50. PubMed ID: 25795041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
    Green RC; Goddard KAB; Jarvik GP; Amendola LM; Appelbaum PS; Berg JS; Bernhardt BA; Biesecker LG; Biswas S; Blout CL; Bowling KM; Brothers KB; Burke W; Caga-Anan CF; Chinnaiyan AM; Chung WK; Clayton EW; Cooper GM; East K; Evans JP; Fullerton SM; Garraway LA; Garrett JR; Gray SW; Henderson GE; Hindorff LA; Holm IA; Lewis MH; Hutter CM; Janne PA; Joffe S; Kaufman D; Knoppers BM; Koenig BA; Krantz ID; Manolio TA; McCullough L; McEwen J; McGuire A; Muzny D; Myers RM; Nickerson DA; Ou J; Parsons DW; Petersen GM; Plon SE; Rehm HL; Roberts JS; Robinson D; Salama JS; Scollon S; Sharp RR; Shirts B; Spinner NB; Tabor HK; Tarczy-Hornoch P; Veenstra DL; Wagle N; Weck K; Wilfond BS; Wilhelmsen K; Wolf SM; Wynn J; Yu JH;
    Am J Hum Genet; 2016 Jun; 98(6):1051-1066. PubMed ID: 27181682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology: The $1,000 genome.
    Hayden EC
    Nature; 2014 Mar; 507(7492):294-5. PubMed ID: 24646979
    [No Abstract]   [Full Text] [Related]  

  • 18. Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
    Caulfield T; Evans J; McGuire A; McCabe C; Bubela T; Cook-Deegan R; Fishman J; Hogarth S; Miller FA; Ravitsky V; Biesecker B; Borry P; Cho MK; Carroll JC; Etchegary H; Joly Y; Kato K; Lee SS; Rothenberg K; Sankar P; Szego MJ; Ossorio P; Pullman D; Rousseau F; Ungar WJ; Wilson B
    PLoS Biol; 2013 Nov; 11(11):e1001699. PubMed ID: 24223516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHGRI beats a path to clinical genomics.
    Cancer Discov; 2012 Feb; 2(2):97-8. PubMed ID: 22585836
    [No Abstract]   [Full Text] [Related]  

  • 20. Company profile: Complete Genomics Inc.
    Reid C
    Future Oncol; 2011 Feb; 7(2):219-21. PubMed ID: 21345140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.